<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03679234</url>
  </required_header>
  <id_info>
    <org_study_id>18.01.US.INF</org_study_id>
    <nct_id>NCT03679234</nct_id>
  </id_info>
  <brief_title>Impact of Infant Formula on Caregiver-perceived Intolerance</brief_title>
  <official_title>Impact of Infant Formula on Caregiver-perceived Intolerance</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nestlé</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nestlé</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Understand the impact of switching to a commercially available infant formula on
      gastrointestinal symptoms
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 24, 2018</start_date>
  <completion_date type="Actual">April 1, 2019</completion_date>
  <primary_completion_date type="Actual">April 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>Subjects and their parent/caregiver will be blinded to the intervention product. Care Providers at sites, Investigators, and Outcomes Assessors are unblinded to the intervention product.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Infant GI Symptom Burden</measure>
    <time_frame>3 weeks</time_frame>
    <description>Study personnel will administer questionnaire</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Formula Intake</measure>
    <time_frame>24 hours</time_frame>
    <description>Caregivers will document on diary records</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fussiness</measure>
    <time_frame>24 hours</time_frame>
    <description>Caregivers will document on diary records</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Formula Satisfaction Questionnaire</measure>
    <time_frame>3 weeks</time_frame>
    <description>Study personnel will administer questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse Events</measure>
    <time_frame>24 hours and 3 weeks</time_frame>
    <description>Assessed throughout study</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">51</enrollment>
  <condition>Healthy Infants</condition>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Routine infant formula</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Routine infant formula</intervention_name>
    <description>Routine infant formula with probiotic</description>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy infant

          -  Full-term (&gt; 37 weeks gestation)

          -  Birth weight &gt; 2500 and &lt; 4500 g

          -  14-60 days of age on enrollment

          -  Singleton birth

          -  Infant's mother has elected not to breastfeed prior to enrollment

          -  Infant exclusively formula-fed for at least 5 days prior to enrollment

          -  Caregiver perceives infant as very or extremely fussy according to perceived fussiness
             based on the previous 3 days

          -  Caregiver wishes to switch infant's formula

          -  Has not received solid foods

          -  Having obtained his/her legal representative's informed consent

        Exclusion Criteria:

          -  Known or suspected cow-milk allergy

          -  Currently receiving a specialty infant formula (e.g. thickened, extensively
             hydrolyzed, amino acid-based, metabolic)

          -  Has switched formula more than two times since hospital discharge

          -  Currently experiencing gastrointestinal or respiratory symptoms secondary to an
             ongoing infection or virus (e.g. gastrointestinal infection, upper respiratory
             infection, flu)

          -  Congenital illness or malformation that may affect infant feeding and/or growth

          -  Any readmission to hospital (except for hyperbilirubinemia) prior to enrollment

          -  Receiving probiotic supplements

          -  Infant's family who in the Investigator's assessment cannot be expected to comply with
             treatment (feeding regimen).

          -  Participation in another study that has not been approved as a concomitant study by
             Nestlé Nutrition.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>60 Days</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ryan Carvalho, MD</last_name>
    <role>Study Director</role>
    <affiliation>Nestle Nutrition</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Norwich Pediatrics Group</name>
      <address>
        <city>Norwich</city>
        <state>Connecticut</state>
        <zip>06360</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Qualmedica Research</name>
      <address>
        <city>Owensboro</city>
        <state>Kentucky</state>
        <zip>42301</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ohio Pediatric Research Association</name>
      <address>
        <city>Dayton</city>
        <state>Ohio</state>
        <zip>45414</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Coastal Pediatric Associates</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29414</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Midsouth Center for Clinical Research, LLC</name>
      <address>
        <city>Memphis</city>
        <state>Tennessee</state>
        <zip>38116</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ClinPoint Trials</name>
      <address>
        <city>Waxahachie</city>
        <state>Texas</state>
        <zip>75165</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tanner Clinic</name>
      <address>
        <city>Layton</city>
        <state>Utah</state>
        <zip>84041</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>September 19, 2018</study_first_submitted>
  <study_first_submitted_qc>September 19, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">September 20, 2018</study_first_posted>
  <last_update_submitted>June 8, 2020</last_update_submitted>
  <last_update_submitted_qc>June 8, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

